Digestive Enzyme Supplement Market Updates

Digestive Enzyme Supplement Market size was valued at USD 3.63 Billion in 2023 and is poised to grow from USD 3.7 Billion in 2024 to USD 4.3 Billion by 2032, growing at a CAGR of 1.9% during the forecast period (2025-2032).

Due to a lack of significant product differentiation in the market, the industry is highly competitive. In both the U.S. and Canada, there are a lot of market participants. A few of the top players on the market are Klaire Laboratories, National Enzyme Company, ProteoZymes, Metagenics, Douglas Labs, and Integrative Therapeutics. 'Abbott Laboratories (US) ', 'Amway Corporation (US) ', 'Bayer AG (Germany) ', 'Glanbia plc (Ireland) ', 'Herbalife Nutrition Ltd. (US) ', 'Nature's Bounty (US) ', 'Garden of Life (US) ', 'Nu Skin Enterprises (US) ', 'Lonza Group Ltd. (Switzerland) ', 'NOW Foods (US) ', 'Klaire Labs (US) ', 'National Enzyme Company (US) ', 'Metagenics (US) ', 'Integrative Therapeutics (US) ', 'Enzymedica (US) ', 'Biotics Research Corporation (US) ', 'Pure Encapsulations (US) ', 'Solgar Inc. (US) '

The prevalence of digestive problems such lactose intolerance, inflammatory bowel disease, and irritable bowel syndrome has significantly increased. Due to this, there is an increase in demand for supplements that help with digestion and lessen the symptoms of certain disorders.

Athletes and fitness enthusiasts are increasingly using digestive enzyme supplements to improve performance and lessen pain in their muscles. This has caused the market for digestive enzyme supplements to increase in the sports nutrition sector.

With a volume share of 46.3% in 2021, North America was the largest market. This region is predicted to continue to lead the market due to rising usage, a decrease in calorie content, and excellent nutritional value. Over the projected period, it is expected that growing consumer awareness of nutritional products in Mexico as a result of the introduction of new products will encourage the use of supplements.